Clinical studies have shown that in type 1 diabetes, glucose, administered either intravenously or orally, can actually stimulate glucagon secretion [28], while the glucagon response to low glucose is blunted [29], [30], indicating that these “opposite” or “paradoxical” changes in the glucagon dynamics may lead to disrupted glucose homeostasis. This evidence concerns the gene GCG and type 1 diabetes mellitus.